Insider Trading Alert - CODE, COV And STXS Traded By Insiders
at The Street - Tue Dec 09, 10:37AM CST
Stocks with insider trader activity include CODE, COV and STXS
COV: 100.49 (-1.36), STXS: 1.42 (unch), CODE: 31.31 (-0.11)
Stereotaxis' CEO William Mills on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 5:10PM CST
STXS: 1.42 (unch)
Stereotaxis Q3 EPS of -$0.10
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:42PM CST
STXS: 1.42 (unch)
Stereotaxis Reports 2014 Third Quarter Financial Results
GlobeNewswire - Wed Nov 05, 3:37PM CST
-Improves System Revenue 89% Sequentially from Second Quarter 2014-
STXS: 1.42 (unch)
Stereotaxis (STXS) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST
STXS: 1.42 (unch)
Stereotaxis to Report Third Quarter 2014 Financial Results on November 5, 2014
GlobeNewswire - Thu Oct 30, 3:49PM CDT
Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2014 third quarter ended September 30, 2014 on Wednesday, November 5, 2014 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company's results and corporate developments.
STXS: 1.42 (unch)
Stereotaxis Secures First Niobe(R) System Order in Japan
GlobeNewswire - Wed Sep 24, 5:30AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has received the first commercial order for its Niobe(R) ES magnetic navigation system in Japan from a leading hospital in Osaka. As part of its primary market strategy, the Company also announced it has established a business office in Japan under the leadership of its new Business Director, who will oversee development and operational activities, including serving as liaison with the Company's in-country distributors and other local resources.
STXS: 1.42 (unch)
Stereotaxis Receives FDA Clearance of Vdrive(TM) With V-Loop(TM) System
GlobeNewswire - Thu Sep 04, 5:35AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive(TM) Robotic Navigation System with V-Loop(TM) Variable Loop Catheter Manipulator in the U.S. The Company submitted a 510(k) Premarket Notification for the Vdrive with V-Loop system in March, following completion of a 120-patient, multi-center clinical study.
STXS: 1.42 (unch)
Stereotaxis Reports 2014 Second Quarter Financial Results
GlobeNewswire - Mon Aug 04, 3:05PM CDT
-Achieves Second Consecutive Quarter of Strong Recurring Revenue-
STXS: 1.42 (unch)
Stereotaxis to Report Second Quarter 2014 Financial Results on August 4, 2014
GlobeNewswire - Mon Jul 28, 5:30AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2014 second quarter ended June 30, 2014 on Monday, August 4, 2014 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company's results and corporate developments.
STXS: 1.42 (unch)
Stereotaxis to Present Niobe(R) System Technology at Japan Heart Rhythm Society
GlobeNewswire - Mon Jul 21, 6:09AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will present at the 29 Annual Meeting of the Japanese Heart Rhythm Society in Tokyo beginning July 23, 2014. The three-day event is the first large-scale opportunity for the Company's in-country distributors, Medix Japan, Inc. and Hokushin Medical Co. Ltd., to promote the clinical value of the Stereotaxis Niobe(R) Magnetic Navigation System for cardiac ablations to the Japan electrophysiology (EP) market. Stereotaxis entered into an agreement with the two medical device distributors in February 2014 to market, sell and distribute the Niobe system and disposable devices to Japanese customers.
STXS: 1.42 (unch)
Stereotaxis to Highlight Efficiency, Efficacy and Safety of Its Technology at Cardiostim 2014
GlobeNewswire - Mon Jun 16, 5:30AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will participate in Cardiostim 2014, the biennial scientific congress of the European Heart Rhythm Association (EHRA), to be held June 18-21, 2014 in Nice, France. The event represents the largest conference attended by the Company in Europe, expected to draw more than 5,600 electrophysiology (EP) and cardiology professionals from Europe and around the world.
STXS: 1.42 (unch)
Stereotaxis Submits 510(k) Application to FDA for Vdrive(TM) with V-Loop(TM) System
GlobeNewswire - Tue Apr 01, 5:30AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has submitted a 510(k) Premarket Notification with the Food and Drug Administration (FDA) for the Company's Vdrive(TM) Robotic Navigation System with V-Loop(TM) Variable Loop Catheter Manipulator. This submission includes both the single arm system (Vdrive) and the two arm system (Vdrive Duo). If cleared by the FDA, the Vdrive with V-Loop system will be the Company's second Vdrive product to be cleared for use in the U.S. Its Vdrive with V-Sono(TM) Intracardiac Echocardiography Catheter Manipulator received FDA clearance in July 2013 and has been utilized in more than 75 cardiac ablation procedures to date in North America.
STXS: 1.42 (unch)
Stereotaxis Expands Credit Facility With Silicon Valley Bank to $10 Million
GlobeNewswire - Mon Mar 31, 5:30AM CDT
Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has entered into an amended credit agreement with Silicon Valley Bank (SVB) that replaces its existing $3 million revolving facility with a $10 million revolving facility scheduled to mature on March 31, 2015.
STXS: 1.42 (unch)
Improved Stock Price Performance of HealthCare Related Companies - Research Report on Omega, BioScrip, Accuray, Stereotaxis and Sagent Pharmaceuticals
PR Newswire - Fri Dec 20, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Omega Healthcare Investors Inc. (NYSE: OHI), BioScrip Inc. (NASDAQ: BIOS), Accuray Incorporated (NASDAQ: ARAY), Stereotaxis Inc. (NASDAQ: STXS), and Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
OHI: 38.96 (+0.38), SGNT: 27.85 (-0.65), BIOS: 5.91 (-0.12), JWN: 74.65 (+0.46), ARAY: 6.95 (+0.04), STXS: 1.42 (unch)